Efficacy and safety of tacrolimus treatment for neuromyelitis optica spectrum disorder
Abstract Neuromyelitis optica spectrum disorder (NMOSD) is a severe inflammatory autoimmune disease that mainly involves the optic nerves and spinal cord, causing blindness and paralysis. Although some immunosuppressants such as rituximab and azathioprine have proven to be effective in relapse preve...
Guardado en:
Autores principales: | Bo Chen, Qian Wu, Gaotan Ke, Bitao Bu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1f137cfed6b04df994fecc21c524491f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Safety and efficacy of interleukin-6-receptor inhibitors in the treatment of neuromyelitis optica spectrum disorders: a meta-analysis
por: Sanjeev Kharel, et al.
Publicado: (2021) -
Paraneoplastic neuromyelitis optica spectrum disorder associated with breast cancer
por: Yuan J, et al.
Publicado: (2019) -
Simultaneous new onset of neuromyelitis optica spectrum disorder in identical twins
por: Ivo Bekavac, et al.
Publicado: (2021) -
Multimodal magnetic resonance imaging in relation to cognitive impairment in neuromyelitis optica spectrum disorder
por: Su-Hyun Kim, et al.
Publicado: (2017) -
Complexity and wide range of neuromyelitis optica spectrum disorders: more than typical manifestations
por: Han J, et al.
Publicado: (2017)